First announced in September 2025, the online platform is set to offer access to prescription medications at steep discounts, ...

The Trump administration’s announcement of the first MFN agreement is a major drug pricing policy milestone. Industry and policymakers await the release of the administration’s Global Benchmark for ...

The Trump Administration has announced its desire to impose price controls on drugs – officially called a most favored nation (MFN) policy. Essentially, the policy sets the price for the targeted ...

On May 12, President Trump issued an Executive Order (EO) on drug pricing: “Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients.” The EO requires a 30-day government ...

On July 31, the Trump administration called on drug manufacturers to lower prescription drug prices in the U.S. to "most favored nation" – or MFN – pricing, the lowest cost paid for the same ...

AbbVie has become one of a swathe of big pharma companies to sign a drug pricing agreement with the Trump administration under its Most Favored Nation (MFN) policy, while committing $100bn to its US R ...

Pharmaceutical research and development (R&D) is unlikely to be significantly impacted by most favored nation (MFN) pricing, according to industry experts. The US bears the highest drug costs globally ...

President Donald Trump sent letters July 31 to the CEOs of 17 major drug manufacturers doing business in the U.S., giving them 60 days to comply with his May 12 executive order (EO) on ...

US MFN rules and new tariffs are narrowing the US–ex-US price gap and drawing more manufacturing and capital investment toward the United States. Low European or UK list prices now directly affect US ...